uniQure(QURE)

4.56 -0.19 -4.0%

今开:4.77昨收:4.75
最高:4.78 最低:4.48
涨停价:0.0跌停价:0.0
总市值:2.21125148E8

uniQure的热门讨论

超过5%股东持股披露

uniQure(QURE)02-14 05:35

$uniQure(QURE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001482  Act: 34  Size: 64 KB 网页链接查看全文

员工持股计划

uniQure(QURE)02-28 21:35

$uniQure(QURE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-24-001917  Act: 33  Size: 169 KB 网页链接查看全文

持股变动声明

uniQure(QURE)02-29 05:45

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000191  Size: 5 KB 网页链接查看全文

持股变动年度报告

uniQure(QURE)02-07 06:35

$uniQure(QURE)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000112  Size: 6 KB 网页链接查看全文

持股变动声明

uniQure(QURE)03-06 06:25

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000203  Size: 7 KB 网页链接查看全文

当期报告

uniQure(QURE)04-12 19:05

$uniQure(QURE)$ 8-K Current report, item 5.02 Accession Number: 0001558370-24-004994  Act: 34  Size: 145 KB 网页链接查看全文

持股变动声明

uniQure(QURE)03-06 06:15

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000201  Size: 7 KB 网页链接查看全文

当期报告

uniQure(QURE)02-28 21:05

$uniQure(QURE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-028484  Act: 34  Size: 328 KB 网页链接查看全文

超过5%股东持股披露「修订」

uniQure(QURE)02-09 23:15

$uniQure(QURE)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001582  Act: 34  Size: 8 KB 网页链接查看全文

证券出售报告

uniQure(QURE)02-27 05:35

$uniQure(QURE)$ 144 Report of proposed sale of securities Accession Number: 0001973379-24-000061  Act: 33  Size: 4 KB 网页链接查看全文

1 2 3

uniQure的新闻

H.C. Wainwright:重申uniQure(QURE.US)“买入”评级 予目标价90美元

智通财经APP获悉,H.C. Wainwright分析师Patrick Trucchio重申uniQure(QURE.US)“买入”评级,并给予目标价90美元。在辉瑞公司(PFE.US)公布了基因疗法fidanacogene elaparvovec用于治疗中重度至重度B型血友病的3期BENEGENE-2试验的主要... 网页链接

uniQure的公告

股东委托书协议

$uniQure(QURE)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-005525  Act: 34  Size: 4 MB 网页链接

其他

$uniQure(QURE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-005526  Act: 34  Size: 538 KB 网页链接

其他

$uniQure(QURE)$ PRE 14A Other preliminary proxy statements Accession Number: 0001558370-24-004996  Act: 34  Size: 4 MB 网页链接

当期报告

$uniQure(QURE)$ 8-K Current report, item 5.02 Accession Number: 0001558370-24-004994  Act: 34  Size: 145 KB 网页链接

持股变动声明

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000203  Size: 7 KB 网页链接

持股变动声明

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000199  Size: 7 KB 网页链接

持股变动声明

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000201  Size: 7 KB 网页链接

持股变动声明

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000197  Size: 7 KB 网页链接

持股变动声明

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000195  Size: 7 KB 网页链接

持股变动声明

$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000191  Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66